Ghaste of IDFC Capital said.
“One has to consistently perform on quality and control to meet regulatory standards globally. Also, the investor should be aware of the frequent changes in regulations and pricing policies as that can affect the bottomline,” said Chhabria of Actis.
“Though investor interest is huge, the investment is coming only at growth stage and not earlier, which involves higher risk. But possibilities for further investments are huge,” concluded Velu of Trivitron Healthcare.